PodcastsCienciasHematologic Oncology Update

Hematologic Oncology Update

Dr. Neil Love
Hematologic Oncology Update
Último episodio

138 episodios

  • Hematologic Oncology Update

    Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances

    20/04/2026 | 58 min
    Dr Amir Fathi from Massachusetts General Hospital in Boston, Massachusetts, and Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discuss key clinical trial data surrounding the use of menin inhibitors in the management of AML.
    CME information and select publications here.
  • Hematologic Oncology Update

    CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson

    10/04/2026 | 24 min
    Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
    CME information and select publications here.
  • Hematologic Oncology Update

    Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review

    01/04/2026 | 24 min
    Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.
    CME information and select publications here.
  • Hematologic Oncology Update

    CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson

    23/03/2026 | 24 min
    Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
    CME information and select publications here.
  • Hematologic Oncology Update

    Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review

    21/03/2026 | 29 min
    Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.
    CME information and select publications here.

Más podcasts de Ciencias

Acerca de Hematologic Oncology Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
Sitio web del podcast

Escucha Hematologic Oncology Update, Jefillysh: Ciencia Simplificada y muchos más podcasts de todo el mundo con la aplicación de radio.net

Descarga la app gratuita: radio.net

  • Añadir radios y podcasts a favoritos
  • Transmisión por Wi-Fi y Bluetooth
  • Carplay & Android Auto compatible
  • Muchas otras funciones de la app

Hematologic Oncology Update: Podcasts del grupo

Aplicaciones
Redes sociales
v8.8.11| © 2007-2026 radio.de GmbH
Generated: 4/22/2026 - 2:57:25 AM